Tracers / [90Y]Y-90-DOTATOC/DOTATATE
[90Y]Y-90-DOTATOC/DOTATATE
Also written as Y-90-DOTATOC/DOTATATE
- Radionuclide
- Y-90 t½ 3843.6 min
- Modality
- Therapy
- Production route
- —
- Stage
- —
- Syntheses indexed
- 1
What it is
- Compound class
- —
- Target / mechanism
- —
- Clinical application
- Metastasized neuroendocrine tumours (NET) PMID 35577489
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| — | — | HPLC | >90% | — | CP04 | 26315862 2015 Nucl Med Rev Cent East Eur Complex formation needed 5 min in microwave oven or 12 min in thermo-block at 95°C. — Yields of CP04 radiolabelling were greater than 90% for all three radionuclides. |
Need this precursor?We can point you to suppliers for [90Y]Y-90-DOTATOC/DOTATATE, or handle the enquiry for you.
Get in touchNotes
Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.